IHL 0.00% 4.1¢ incannex healthcare limited

This is why IHL is chasing Novel drugs. The sleep market is very...

  1. 407 Posts.
    lightbulb Created with Sketch. 405
    This is why IHL is chasing Novel drugs. The sleep market is very saturated and you would need mind blowing results to create a new drug.
    That being said, early results of our OSA drug are exceptional.
    The combination drug IP is what sets us apart with all our candidates.
    Disappointing for CAN but not sure why you would be even trying to do what they are doing.

 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.